The beta-adrenergic action is thought to be related to the ability of the beta-adrenergic stimulants to increase the intracellular level of cyclic adenosine 3’,5’-monophosphate (cyclic AMP) in the smooth muscle (1). Recently some workers (2,3) have mentioned that papaverine, a smooth muscle relaxant, is found to strongly inhibit cyclic phosphodiesterase in rabbit aorta and rat uterus. On the other hand, Takagi, Takayanagi and Tomiyama (4, 5) have reported that the relaxing effects of papaverine and isoprenaline, a beta-adrenergic stimulant, are identical to exogenous dibutyryl cyclic AMP and that these drugs suppress a supply of calcium to the contractile protein at the membrane, Further, Takagi, Takayanagi and Tsuchida (6) have also indicated using the taenia from the guinea pig caecum that caffeine and imidazole, which influence phosphodiesterase activity, considerably modify the responses of the taenia to isoprenaline and papaverine, while the action of phenylephrine, an alpha-adrenergic stimulant, is slightly affected by caffeine and imidazole. These results indicate the possibilities that the actions of beta-adrenergic stimulants and papaverine are mediated through an increase of the intracellular level of cyclic AMP and that cyclic AMP is not concerned with the response to alpha-adrenergic stimulants.
Read full abstract